Sidebar

services

Rapolas Zilionis  


Email:


LinkedIn

 

Research Group
Research Interests: Droplet microfluidics
Single-cell sequencing
Molecular biology method development 
Present Position: Senior researcher, Sector of Microtechnologies, Institute of Biotechnology, Life Sciences Center, Vilnius University
Chief Scientific Officer, Droplet Genomics 
Education:
 2019 - PhD in Physical sciences (Biochemistry), Vilnius University
2014 - MSc in Biochemistry, Vilnius University
2012 - BSc in Biochemistry, Vlnius University 
Experience (Past Positions): 2014–present - Researcher, Sector of Microtechnologies, Life Sciences Center, Vilnius University, Lithuania
2019–present - CSO, Droplet Genomics, Lithuania
2015–2018 - Visiting Fellow, Harvard Medical School, USA
July–October 2013 - Intern, Ludwig Institute for Cancer Research, Oxford University, UK
2010–2014 - Research Assistant, ThermoFisher Scientific Baltics, Lithuania 
Single-cell RNAseq data analysis with Python 
Awards: 2020 Winner in Young Scientist Best Research Work competition – Lithuanian Academy of Sciences
2019 Vilnius University Rector's award 
2019 Award for Best Publication of 2018 in the field biomedicine – Vilnius University 
Publications: LABT_LMAVB 
GoogleScholar

Projects and Grants:

As lead investigator:
13.1.1-LMT-K-718-05-0004 Development of a highly sensitive digital RT-PCR method for absolute quantification of SARS-CoV-2 virus.

As executor:
2020–2021 - 01.2.2-LMT-K-718-04-0002 "Establishment of a parallel laboratory for single-cell transcriptomic-genomic research". 
2018–2020 - 09.3.3-LMT-K-712-01-0056 "Microfluidic technologies for genotype-phenotype studies of single cells".
2017 - S-MIP-17-58 "Single-cell technology for genomic DNA modification study and analysis of neuroblastoma epigenetic heterogeneity".
2014–2015 - CH-3-ŠMM-01/03 "Evolution of computer-modeled enzymes using microfluidic technologies".
2018–2019 - NIH R01-CA218579, "Single-cell genome-wide myeloid response profiling in immunotherapy".
2017–2018 - NIH R33-CA212697-01, "Droplet microfluidic technology for single-cell cancer genomics".
Languages: Lithuanian (native), English, French, Russian

 

Research

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies. More information